Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jul 11, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The CHoBI7 trial is studying a program designed to help reduce cholera and other diarrheal diseases, especially in young children. The goal is to see if providing a simple package that includes a bottle of soapy water and chlorine tablets can improve water quality and hygiene practices in both urban and rural areas. The researchers aim to test this program in local health facilities, focusing on how well it encourages better handwashing and reduces the spread of diarrhea.
To participate in this trial, you need to be a patient experiencing diarrhea with three or more loose stools in a day and live in a home without running water. It’s also important that you have a child under five years old living with you and that you plan to stay in your current home for at least three months. If you join, you can expect to receive support and resources to help improve hygiene practices in your household. The trial is open to everyone, regardless of age, gender, or background, and aims to make a positive impact on health in your community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diarrhea patients presenting with three or more loose stools over a 24h period
- • Having no running water inside of the patient's home
- • Plan to reside in current residence for the next 3 months
- • Have a child \<5 years in the patient's household
- • Have a working mobile phone in the household
- Exclusion Criteria:
- • No one will be excluded because of age, sex, religion, or sexual preference
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manikganj, , Bangladesh
Patients applied
Trial Officials
Christine Marie George, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported